HOME >> MEDICINE >> NEWS
Potential heart benefit found in stem cells

ATLANTA, GA (March 12, 2006) -- Stem cell transplantation is among one of the most exciting and hotly debated areas of medical research today. While the promise of personalized medicine and effective treatments for debilitating diseases drive progress in this area, moral and ethical dilemmas about embryonic cells continues to cloud the field. In research presented today at the American College of Cardiology's 55th Annual Scientific Session, scientists continue to explore mature stem cell sources for potentially significant cardiovascular benefits. ACC.06 is the premier cardiovascular medical meeting, bringing together over 30,000 cardiologists to further breakthroughs in cardiovascular medicine.

"We hope that the exploration of stem cells derived from new sources may bypass some of the debate that is preventing research progress right now," said Sharon A. Hunt, M.D., Stanford University. "The research presented here is extremely promising, and should be followed by more in-depth and patient-focused studies to determine the true feasibility of this treatment method."

Human Menstrual Blood Derived Stem Cell Has a High Cardiomyogenic Potential; Possible New Cell Source for Cardiac Stem Cell Therapy (Abstract 921-105) / Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Has A Powerful Cardiomyogenic Potential in Vitro; A Novel Cell Source for Cardiac Stem Cell Based Therapy (Abstract 921-107)

Some previous research on the efficacy of stem cell therapy for heart repair has shown benefit from mesenchymal stem cells (often found in bone marrow), but mostly because assist in the growth of new blood vessels. The true benefit of stem cells to heart function, however, may be in promoting cardiomyogenesis (CM, the growth of cardiac muscle). To achieve CM, the source of the cells needs a high rate of cardiac activity and similar gene and protein expression. In two studies presented from researchers at the Keio University School of
'"/>


13-Mar-2006


Page: 1 2 3 4 5

Related medicine news :

1. Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai
2. Potential association between skin cancer cream and improvements of prematurely aged skin
3. Potential treatment for intracerebral hemorrhage under study
4. Potential pharmaceutical drugs in the field of cancer
5. Potential new treatment for insulin-dependent diabetes
6. Potential weak link between virus and liver cancer discovered
7. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
8. Drug for cluster headaches may cause heart problems
9. Reductive stress linked to heart disease
10. Novel candidate biomarker for heart failure also strongly predicts risk of death
11. Many heart attack patients still not getting emergency clot-busting treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... ... November 30, 2016 , ... ... clinical research community that the FDA Binding Guidance goes into effect next month. ... formats listed in the FDA Data Standards Catalog. The current FDA Data Standards ...
(Date:11/30/2016)... ... November 30, 2016 , ... U.S. Security Associates (USA) ... services based in Richmond, Virginia. The acquisition further strengthens USA’s capabilities within ... security services and prides itself on 100% client-retention to the healthcare industry. In ...
(Date:11/30/2016)... Philadelphia, PA (PRWEB) , ... November 30, 2016 ... ... and pharmaceutical organizations to build intelligent, connected applications, announces today that it has ... (HITRUST). , CloudMine, has been self-certified as compliant with the HITRUST CSF ...
(Date:11/30/2016)... ... November 30, 2016 , ... Staying on top ... deductibles, more restrictive lists of healthcare providers and soaring drug costs. To help ... estimator tools, offered by New York health plans. These tools, which are ...
(Date:11/30/2016)... Linda, Ca (PRWEB) , ... November 30, 2016 , ... ... in Best in Biz Awards, the only independent business awards program judged by members ... progress as it drives revenue and growth, while maintaining partner relations. In 2015 LabRoots ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 CVS Health ... annual Analyst Day in New York City on Thursday, December 15, 2016, ... Health leadership team will provide an in-depth review of ... shareholder value. The company will also discuss 2017 earnings ... video webcast of the event will be broadcast simultaneously ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Extremity Braces & Support) is Expected to Gain a Significant ... Prone to Orthopedic Ailments  ... , , According ... Market Study on Medical Implants Sterile Packaging: Clamshell Product Type ...
(Date:12/2/2016)...   CytoSorbents Corporation (NASDAQ: CTSO ), ... approved CytoSorb ® cytokine adsorber to treat deadly ... that Dr. Phillip Chan , Chief Executive Officer, ... Main Event investor conference held from December 6 ... Boulevard Hotel in Los Angeles, California ...
Breaking Medicine Technology:
Cached News: